Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Study of LY2835219 in Combination With Multiple Single Agent Options for Patients With Stage IV NSCLC

NCT02079636 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT02079636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02079636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Study of LY2835219 in Combination With Multiple Single Agent Options for Patients With Stage IV NSCLC
Lead sponsor
Eli Lilly and Company
Phase
Phase 1
Overall status
Completed
Start date
March 28, 2014
Completion date
August 29, 2019
Enrollment
142 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, non-small cell lung